The Business Research Company’s report on the Animal Biotechnology Market provides insights into the global market size, growth rate, regional distribution, competitive landscape, key segments, emerging trends, and strategic opportunities.
How are market drivers shaping the future growth trajectory of the animal biotechnology industry?
The growing awareness regarding animal health and welfare is expected to propel the animal biotechnology market going forward. Animal health and welfare are concerned with how people interact with animals and their responsibility to ensure that the animals in their care are handled appropriately and compassionately. In animal health and welfare, animal biotechnology helps in improving animal productivity via increasing growth, reproduction quality, nutrition, feed utilization, food safety, and others for more efficient utilization of resources. For instance, in May 2023, the Humane Society launched the More Than a Pet campaign, emphasizing the importance of equitable access to veterinary care, particularly for underserved communities. Through this initiative, over 14,800 pets received 64,000 services in 2023 via community outreach programs aimed at improving animal welfare in low-resource areas. The campaign focuses on providing essential veterinary care and support to improve the well-being of animals in underserved regions. Therefore, the growing awareness regarding animal health and welfare is driving the growth of the animal biotechnology market.
Access Your Free Sample of the Global Animal Biotechnology Market Report – Get Insights Now!
https://www.thebusinessresearchcompany.com/sample.aspx?id=8059&type=smp
What is the estimated market size of the animal biotechnology sector by 2029, based on current forecasts?
The animal biotechnology market size has grown strongly in recent years. It will grow from $30.33 billion in 2024 to $32.97 billion in 2025 at a compound annual growth rate (CAGR) of 8.7%. The growth in the historic period can be attributed to genetic improvement, increased agricultural productivity, vaccines and therapeutics, environmental sustainability, feed efficiency, nutritional enhancement, reduced environmental impact.
The animal biotechnology market size is expected to see rapid growth in the next few years. It will grow to $48.68 billion in 2029 at a compound annual growth rate (CAGR) of 10.2%. The growth in the forecast period can be attributed to development of disease-resistant strains, biopharmaceutical production, cell-based meat production, global food security concerns, regulatory support, public and consumer acceptance. Major trends in the forecast period include genome editing technologies, genome editing technologies, animal stem cell technology, biopharmaceutical production in animals, biobanking and genetic resource preservation, emergence of Crispr-based therapies, biosecurity and disease surveillance.
Gain Exclusive Market Insights—Customize Your Research Report Today For Fast Delivery!
https://www.thebusinessresearchcompany.com/customise?id=8059&type=smp
#Who are the top players in the animal biotechnology market?
Major companies operating in the animal biotechnology market are Zoetis Inc., Boehringer Ingelheim International GmbH, Biogenesis Bago SA, Merck & Co Inc., Virbac, Elanco Animal Health Incorporated, Randox Laboratories Ltd., Santa Cruz Biotechnology Inc., IDEXX Laboratories Inc., IDVet, Heska Corporation, INDICAL BIOSCIENCE GmbH, BioChek BV, Ceva Santé Animale, Dalan Animal Health, Vetigenics, Vetoquinol S.A., Neogen Corporation, Abaxis Inc., Henry Schein Animal Health, Patterson Companies Inc., Covetrus Inc., Phibro Animal Health Corporation, Novartis Animal Health, Bayer AG, Bioniche Life Sciences Inc., Bio-Rad Laboratories Inc., Biovet JSC, Bovogen Biologicals Pty Ltd.
#What are the major trends in the animal biotechnology market?
Product innovation is a key trend in the animal biotechnology market. Major market players are focusing their efforts on developing novel goods like virus-like particle (VLP) technology for vaccine development. For instance, in April 2022, Cadila Pharmaceuticals, an India-based multinational pharmaceutical company, introduced a three-dose rabies vaccine prepared using virus-like particle technology for rabies known as ThRabis. Virus-like particles (VLPs) refer to a vaccine-developing technique that uses multiprotein structures to mimic the form and size of a virus particle but lacks the viral genome that potentially yields safer and cheaper vaccine candidates. ThRabis consists of recombinant nanoparticle-based rabies G protein that generates antibodies against rabies G protein that neutralize the virus and impedes virus attachment to the cell to achieve protection against rabies.
Which geography holds the highest animal biotechnology market share?
North America was the largest region in the animal biotechnology market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the animal biotechnology market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Order Your Report Now For Swift Delivery
https://www.thebusinessresearchcompany.com/report/animal-biotechnology-global-market-report
How do different segments contribute to the overall expansion of the animal biotechnology market?
The animal biotechnology market covered in this report is segmented –
1) By Product Type: Diagnostics Tests, Vaccines, Drugs, Reproductive And Genetic, Feed Additives
2) By Animal Type: Companion, Livestock
3) By Application: Diagnosis Of Animal Diseases, Treatment Of Animal Diseases, Preventive Care Of Animals, Drug Development, Other Applications
4) By End-Use: Laboratories, Point-Of-Care Testing Or In-house Testing, Veterinary Hospitals And Clinics, Other End-Uses
Subsegments:
1) By Diagnostics Tests: Immunodiagnostic Tests, Molecular Diagnostic Tests, Biochemical Diagnostic Tests
2) By Vaccines: Inactivated Vaccines, Live Attenuated Vaccines, Recombinant Vaccines
3) By Drugs: Antimicrobial Drugs, Anti-Inflammatory Drugs, Hormonal Drugs
4) By Reproductive And Genetic: Genetic Testing Services, Artificial Insemination Products, Embryo Transfer Technologies
5) By Feed Additives: Probiotics, Enzymes, Nutraceuticals
Purchase The Exclusive Report Now To Unlock Valuable Market Insights:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=8059
What defines the structure and scope of the animal biotechnology market?
Animal biotechnology refers to the use of science and engineering techniques by which living organisms are modified to benefit humans and other animals. Animal biotechnology is used to modify the genome of animals, known as genetic engineering, to improve their suitability in pharmaceuticals, industrial, and agriculture applications.
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.
Our flagship product, the Global Market Model, is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.
Contact Us:
The Business Research Company
https://thebusinessresearchcompany.com/
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: [email protected]
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
